Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Contrave
Contrave
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus
TheStreet.com
Sat, 02/21/15 - 09:44 am
obesity
Orexigen
Arena
Vivus
Belviq
Contrave
Qsymia
Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
Seeking Alpha
Wed, 02/18/15 - 10:52 am
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Contrave
Belviq
Orexigen Provides Progress Update on Mysimba European Marketing Authorization
Yahoo
Mon, 02/9/15 - 06:16 pm
Orexigen
Europe
Mysimba
Contrave
Orexigen: Contrave Scripts Slow Down - Competition Lowers Price
Seeking Alpha
Tue, 02/3/15 - 09:01 am
Orexigen
Contrave
obesity
Arena - Flat Scripts Is Not A Good Start To 2015
Seeking Alpha
Wed, 01/28/15 - 08:06 am
Arena Pharmaceuticals
Eisai
Belviq
obesity
Contrave
Orexigen
Orexigen Scripts Continue Impressive Track
Seeking Alpha
Wed, 01/21/15 - 06:02 pm
Orexigen
obesity
Contrave
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
APD334
Vivus
Qsymia
EnteroMedics
devices
Maestro System
Novo Nordisk
Saxenda
Orexigen's Contrave May Have Pricing Competition
Seeking Alpha
Mon, 01/12/15 - 09:47 am
Orexigen
Contrave
drug pricing
Belviq
Arena Pharmaceuticals
Orexigen - Contrave Script Numbers Remain Impressive
Seeking Alpha
Mon, 12/22/14 - 04:52 pm
Orexigen
Contrave
obesity
Arena And Vivus Investors Need To Grasp Implications Of Orexigen
Seeking Alpha
Fri, 12/19/14 - 04:08 pm
Arena Pharmaceuticals
Vivus
Contrave
Belviq
Qsymia
Orexigen diet pill recommended for approval in Europe
Yahoo/Reuters
Fri, 12/19/14 - 09:46 am
Orexigen
obesity
Contrave
Europe
Mysimba
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals
Adam on Biotech Stocks
Fri, 12/12/14 - 12:33 pm
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
Vivus
Qsymia
Assessing The Beginnings Of The Orexigen Launch Of Contrave
Seeking Alpha
Wed, 12/10/14 - 05:47 pm
Contrave
obesity
Orexigen
drug launches
Takeda
The Odds Of Success For The New Obesity Drugs
CP Wire
Mon, 12/8/14 - 11:45 am
obesity
Belviq
Contrave
Qsymia
Arena Pharmaceuticals
Vivus
Orexigen
For This Obesity Drug, Europe Trumps the U.S.
Motley Fool
Tue, 11/18/14 - 10:06 am
Orexigen
Europe
Contrave
obesity
Obesity drug war may be about more than marketing to the overweight
Medical Marketing and Media
Wed, 11/12/14 - 04:52 pm
obesity
Contrave
Orexigen
Eisai
Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
TheStreet.com
Mon, 11/10/14 - 04:08 pm
Orexigen
Contrave
Europe
Orexigen's Contrave Has Modest Start
Seeking Alpha
Mon, 11/3/14 - 06:42 pm
Orexigen
Contrave
obesity
Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets
Yahoo
Mon, 10/20/14 - 09:10 am
Takeda
Orexigen
Contrave
obesity
Orexigen pockets $100M in milestone cash for Contrave
Fierce Biotech
Wed, 10/15/14 - 12:26 pm
Orexigen
Contrave
Takeda
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »